Russell Investments Group’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $18.1K | Buy |
4,680
+476
| +11% | +$1.84K | ﹤0.01% | 3217 |
|
2025
Q1 | $21K | Sell |
4,204
-174
| -4% | -$870 | ﹤0.01% | 3101 |
|
2024
Q4 | $31.6K | Hold |
4,378
| – | – | ﹤0.01% | 2923 |
|
2024
Q3 | $26.9K | Sell |
4,378
-4,106
| -48% | -$25.2K | ﹤0.01% | 2898 |
|
2024
Q2 | $56.4K | Buy |
8,484
+4,107
| +94% | +$27.3K | ﹤0.01% | 2736 |
|
2024
Q1 | $44.6K | Buy |
4,377
+74
| +2% | +$753 | ﹤0.01% | 2680 |
|
2023
Q4 | $48.4K | Buy |
4,303
+3,959
| +1,151% | +$44.5K | ﹤0.01% | 2642 |
|
2023
Q3 | $894 | Buy |
+344
| New | +$894 | ﹤0.01% | 3351 |
|
2022
Q1 | – | Sell |
-27,000
| Closed | -$247K | – | 2740 |
|
2021
Q4 | $247K | Buy |
+27,000
| New | +$247K | ﹤0.01% | 2663 |
|
2017
Q3 | – | Sell |
-486
| Closed | -$47K | – | 2934 |
|
2017
Q2 | $47K | Sell |
486
-921
| -65% | -$89.1K | ﹤0.01% | 2888 |
|
2017
Q1 | $342K | Buy |
1,407
+694
| +97% | +$169K | ﹤0.01% | 2560 |
|
2016
Q4 | $695K | Buy |
+713
| New | +$695K | ﹤0.01% | 2347 |
|